Investment Summary |
|
---|---|
Date | 2021-12-07 |
Target | Odyssey Therapeutics |
Sector | Life Science |
Investor(s) | HBM Partners AG |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2001 |
PE ASSETS | 3.0B USD |
Size | Mega |
Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
DEAL STATS | # |
---|---|
Overall | 62 of 66 |
Sector (Life Science) | 55 of 57 |
Type (Venture) | 50 of 53 |
State (Massachusetts) | 12 of 13 |
Country (United States) | 42 of 44 |
Year (2021) | 14 of 15 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-07 |
Freenome
South San Francisco, California, United States Freenome develops blood-based tests for early cancer detection, applying its proprietary multiomics platform, deep expertise in molecular biology and advanced machine learning. Freenome was founded in 2014 and is based in South San Francisco, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-08 |
connectRN
Waltham, Massachusetts, United States connectRN builds technologies that revolutionize the way hospitals and healthcare facilities manage their workforce. connectRN platform offers career development resources, flexible shift offerings, and the opportunity to participate in a supportive community of peer professionals. connectRN was founded in 2014 and is based in Waltham, Massachusetts, |
Buy | - |